期刊文献+

c-Met在食管鳞状细胞癌组织中的表达及其与临床病理的相关性 被引量:9

c-Met expression in esophageal squamous cell carcinoma tissues and its correlation with clinicopathological characteristics
下载PDF
导出
摘要 目的检测食管鳞状细胞癌组织及配对癌旁组织中c-Met蛋白的表达情况,探讨c-Met的表达与食管鳞状细胞癌患者临床病理特点的相关性。方法收集87对甲醛固定,石蜡包埋的食管鳞状细胞癌及配对的癌旁组织标本,所有病例均经病理证实,同时收集患者的临床资料。采用免疫组化的方法检测组织中c-Met的表达情况。结果 c-Met主要表达于细胞膜,表现为胞膜呈棕黄色染色。87例食管鳞癌组织中有29例(33.3%)呈阳性表达。配对癌旁组织中未见c-Met表达。c-Met的表达与食管鳞状细胞癌患者的肿瘤浸润深度、淋巴结转移及临床病理分期(tumor-node-metastasis,TNM)存在显著相关性(分别为P=0.017,P=0.000,P=0.000),而与患者的性别、年龄、肿瘤细胞分化程度、肿瘤大小等无明显相关性(P>0.05)。结论 c-Met在部分食管鳞癌组织中呈高表达,且与患者的肿瘤浸润深度、淋巴结转移及TNM分期存在显著相关性,c-Met的高表达可以作为高侵袭性食管鳞癌的分子标志物。 Objective To detect the expression of c-Met in esophageal squamous cell carcinoma tissues(ESCC) and paired non-cancerous tissues,and to investigate the association between c-Met and clinicopathological parameters of ESCC patients.Methods Eighty seven pairs of paraffin-embedded ESCC tissues and paired non-cancerous esophageal tissues were collected from the Department of Pathology,Beijing Friendship Hospital Affiliated To Capital Medical University.Sections from each specimen were examined by a pathologist and graded histologically.Patients' clinical parameters were collected meanwhile.Immunohistochemistry(IHC) was applied to detected the the expression of c-Met in the tissues.Results c-Met positive signals showed brown-yellow granules in the membrane.The expression of c-Met in non-cancerous esophageal tissues was always negative,whereas strong positive staining of c-Met was observed in 29/87(33.3%) of ESCCs.The expression of c-Met was correlated with tumor invasion depth,lymph node metastasis,and TNM(tumor-node-metastasis) stage(P=0.017,P=0.000,P=0.000,respectively).No significant association between c-Met expression and other clinicopathological parameters(patients' gender,age,cell grading,and tumor size) was found(P0.05).Conclusion The overexpression of c-Met was correlated with tumor invasion depth,lymph node metastasis,and TNM stage of ESCC patients.The overexpression of c-Met may be a marker for highly invasive ESCC.
出处 《首都医科大学学报》 CAS 2012年第2期223-226,共4页 Journal of Capital Medical University
基金 国家自然科学基金(81050016) 北京市科委资助项目(Z101100055610031)~~
关键词 食管鳞状细胞癌 C-MET 肝细胞生长因子 临床病理 esophageal squamous cell carcinoma c-Met hepatocyte growth factor clinicopathology
  • 相关文献

参考文献15

  • 1Enzinger P C,Mayer R J. Esophageal cancer[J].New England Journal of Medicine,2003,(23):2241-2252.doi:10.1056/NEJMra035010. 被引量:1
  • 2Trusolino L,Bertotti A,Comoglio P M. MET signalling:principles and functions in development,organ regeneration end cancer[J].Nature Reviews Molecular Cell Biology,2010,(12):834-848. 被引量:1
  • 3Kammula U S,Kuntz E J,Francone T D. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome[J].Cancer Letters,2007,(02):219-228.doi:10.1016/j.canlet.2006.07.007. 被引量:1
  • 4Nakamura Y,Niki T,Goto A. c-Met activation in lung adenocarcinoma tissues:an immunohistochemical analysis[J].Cancer Science,2007,(07):1006-1013.doi:10.1111/j.1349-7006.2007.00493.x. 被引量:1
  • 5Seiwert T Y,Jagadeeswaran R,Faoro L. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma[J].Cancer Research,2009,(07):3021-3031.doi:10.1158/0008-5472.CAN-08-2881. 被引量:1
  • 6方文涛.第7版国际抗癌联盟食管鳞癌TNM分期解读[J].上海交通大学学报(医学版),2011,31(3):265-270. 被引量:31
  • 7Kim C H,Koh Y W,Han J H. c-Met expression as an indicator of survival outcome in patients with oral tongue careinoma[J].Head & Neck,2010,(12):1655-1664. 被引量:1
  • 8Yamamoto S,Tsuda H,Miyai K. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma:their roles in tumor progression and prognostication of the Patient[J].Modern Pathology,2011,(08):1146-1155. 被引量:1
  • 9Grugan K D,Miller C G,Yao Y. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion[J].Proceedings of the National Academy of Sciences(USA),2010,(24):11026-11031. 被引量:1
  • 10Ren Y,Cao B,Law S. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression:a prognostic marker of human esophageal squamous cell carcinomas[J].Clinical Cancer Research,2005,(17):6190-6197. 被引量:1

二级参考文献18

  • 1Yuichiro Doki M.D.,Osamu Ishikawa M.D.,Ko Takachi M.D.,Isao Miyashiro M.D.,Yo Sasaki M.D.,Hiroaki Ohigashi M.D.,Kohei Murata M.D.,Terumasa Yamada M.D.,Shingo Noura M.D.,Hidetoshi Eguchi M.D.,Toshiyuki Kabuto M.D.,Shingi Imaoka M.D..Association of the Primary Tumor Location with the Site of Tumor Recurrence after Curative Resection of Thoracic Esophageal Carcinoma[J]. World Journal of Surgery . 2005 (6) 被引量:1
  • 2Teruo Kakegawa.Forty years’ experience in surgical treatment for esophageal cancer[J]. International Journal of Clinical Oncology . 2003 (5) 被引量:1
  • 3J. R. Siewert,H. J. Stein.Lymph-node dissection in squamous cell esophageal cancer – who benefits?[J]. Langenbeck’s Archives of Surgery . 1999 (2) 被引量:1
  • 4Fang WT,Chen WH.Current trends in extended lymph node dis-section for esophageal carcinoma. Asian Cardiovasc ThoracAnn . 2009 被引量:1
  • 5Bogoevski D,Onken F,Koenig A,et al.Is it ti me for a new TNMclassification in esophageal carcinoma?. Annals of Surgery . 2008 被引量:1
  • 6BP Wijnhoven,KT Tran,A Esterman.An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Annals of Surgery . 2007 被引量:1
  • 7T.W. Rice,V.W. Rusch,C. Apperson-Hansen,M.S. Allen,L.Q. Chen,J.G. Hunter.Worldwide esophageal cancer collaboration. Diseases of the Esophagus . 2009 被引量:1
  • 8Tachibana M,Kinugasa S,Yoshimura H,et al.Clinical outcome ofextended esophagectomy with three-field lymph node dissection for e-sophageal squamous cell carcinoma. The American Journal of Surgery . 2005 被引量:1
  • 9Dutkowski,P,Hommel,G,Bottger,T,Schlick,T,Junginger,T.How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value. Hepato Gastroenterology . 2002 被引量:1
  • 10WT Fang,WH Chen,Y Chen.Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma. Diseases of the Esophagus . 2007 被引量:1

共引文献30

同被引文献74

  • 1罗泊涛,姚运红,李飞虹,蔡琼珍.肝细胞生长因子及其受体c-Met和β-catenin在鼻咽癌中的表达[J].中国现代医学杂志,2008,18(24):3584-3587. 被引量:4
  • 2Shi-Ting Bao, Shui-Qing Gui and Mu-Sheng Lin Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):580-583. 被引量:28
  • 3尹如铁,彭芝兰,杨开选,康德英.Survivin蛋白在卵巢癌中的表达和意义[J].四川大学学报(医学版),2006,37(2):215-217. 被引量:10
  • 4Liu X, Newton RC,Scherle PA ,et al. Developing c - MET pathway inhibitors for cancer therapy : progress and challenges [J]. Trends Mol Med, 2010’ 16(1) :37 -45. 被引量:1
  • 5Livak KJ, Schmittgen TD. Analysis of relative gene expression data u-sing real - time quantitative PCR and the 2(- Delta Delta C ( T)) method [J]. Methods, 2001,25 ¢4) : 402 -408. 被引量:1
  • 6Chen CC , Hou MF, Wang JY, et al. Simultaneous detection of multiple mRNA markers CK19 , CEA,c - Met, Her2/neu and Hmam with membrane array, an innovative technique with a great poten tial for breast cancer diagnosis[ J] ? Cancer Lett, 2006,240(2) :279 - 288. 被引量:1
  • 7Zeng ZS, Weiser MR, Kuntz E,et al. c - Met gene amplification is associated with advanced stage colorectal cancer and liver metastases [J]. Cancer Lett, 2008,265(2) :258 -269. 被引量:1
  • 8Miyamoto M,Ojima H, Iwasaki M, et al. Prognostic significance of o-ver expression of c - Met oncoprotein in cholangiocarcinoma [ J] ? Br J Cancer, 2011 ,105(1) :131 -138. 被引量:1
  • 9Ma PC , Jagadeeswaran R, Jagadeesh S, et aa. Functional expression and mutations of C - met and its therapeutic inhibition with SUI 1274 and small interfering RNA in non—small cell lung cancer[ J ]. Cancer Res,2005. 65(4) :1479 -1488. 被引量:1
  • 10Kahn HJ, Yang LY, Blondal J ,et al. RT - PCR amplification of CK19 mRNA in the blood of breast cancer patients : correlation with established prognostic parameters [ J ]. Breast Cancer Res Treat, 2000, 60 (2) :143 -151. 被引量:1

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部